Japanese Tobacco Stock News

TSE:6460
TSE:6460Leisure

Sega Sammy Holdings (TSE:6460) Q3 Loss Of ¥19.6b Tests Bullish Earnings Recovery Narrative

Sega Sammy Holdings (TSE:6460) just posted Q3 2026 results with revenue of ¥134.1 billion and a basic EPS loss of ¥93.45, while trailing twelve month figures show revenue of ¥441.9 billion and a basic EPS loss of ¥64.19. The company has seen quarterly revenue range from ¥81.0 billion in Q1 2026 to ¥134.1 billion in Q3 2026, alongside EPS swinging between a ¥15.89 loss and a ¥53.26 profit across recent periods. This frames a mixed earnings profile around its current loss. For investors, the...
TSE:7272
TSE:7272Auto

Yamaha Motor (TSE:7272) Margin Squeeze Reinforces Bearish Profitability Narratives

Yamaha Motor (TSE:7272) FY 2025 earnings snapshot Yamaha Motor (TSE:7272) has wrapped up FY 2025 with Q4 revenue of ¥623.9 billion and a basic EPS loss of ¥28.11, as net income excluding extra items came in at a loss of ¥27.3 billion. Over recent quarters, revenue has moved from ¥599.3 billion in Q4 FY 2024 to ¥651.9 billion in Q2 FY 2025 before landing at ¥623.9 billion in Q4 FY 2025. Quarterly EPS has swung from a loss of ¥28.63 in Q4 FY 2024 to a gain of ¥31.47 in Q1 FY 2025 and back to a...
TSE:2579
TSE:2579Beverage

Coca-Cola Bottlers Japan Holdings (TSE:2579) EPS Volatility Tests Earnings Turnaround Narrative

Coca-Cola Bottlers Japan Holdings (TSE:2579) has wrapped up FY 2025 with fourth quarter revenue of ¥210.3 billion and a net loss of ¥2.0 billion, translating to EPS of ¥12.15, while trailing twelve month revenue stood at ¥893.8 billion and a net loss of ¥50.8 billion, or EPS of ¥296.51. Over recent quarters, the company has seen revenue move from ¥216.1 billion and EPS of ¥15.15 in Q4 2024 to a Q3 2025 peak of ¥265.6 billion with EPS of ¥101.42 before the latest quarter. This leaves investors...
TSE:3923
TSE:3923Software

Rakus (TSE:3923) Q3 Earnings Growth Tests Views On Premium P/E Valuation

Rakus (TSE:3923) has put fresh numbers on the table for Q3 2026, with revenue of ¥15.5b and basic EPS of ¥9.11, set against trailing 12 month EPS of ¥33.24 that sits on revenue of ¥57.7b. The company has seen quarterly revenue move from ¥12.6b in Q3 2025 and ¥13.4b in Q4 2025 to ¥14.1b in Q1 2026, ¥14.7b in Q2 2026 and now ¥15.5b in Q3 2026. Over the same stretch, basic EPS has moved from ¥5.41 to ¥6.66, ¥9.79, ¥7.69 and ¥9.11, giving investors a clear line of sight on how profitability is...
TSE:4180
TSE:4180Software

Appier Group (TSE:4180) Margin Compression Challenges High Growth Investor Narratives

Appier Group FY 2025 Earnings Snapshot Appier Group (TSE:4180) has wrapped up FY 2025 with fourth quarter revenue of ¥12.7b and basic EPS of ¥8.81, alongside net income of ¥897m, putting fresh numbers behind the current share price at ¥953. Over the last six reported quarters, the company has seen quarterly revenue move from ¥9.05b in Q3 2024 to ¥9.35b in Q1 2025, then to ¥10.31b in Q2 2025, ¥11.37b in Q3 2025, and ¥12.7b in Q4 2025, while basic EPS shifted from ¥7.97 to ¥0.34, ¥5.48, ¥10.5,...
TSE:4578
TSE:4578Pharmaceuticals

Otsuka Holdings (TSE:4578) Is Up 13.3% After Launching ¥50 Billion Buyback And Raising 2025 Dividend

On February 13, 2026, Otsuka Holdings Co., Ltd. announced a share repurchase program of up to 7,000,000 shares for ¥50,000 million, alongside a higher dividend of ¥70.00 per share for 2025 and reaffirmed dividend guidance for 2026. This combination of buybacks, dividend increase, and confirmed earnings and dividend guidance highlights management’s focus on capital efficiency and cash returns to shareholders. We’ll now explore how the newly announced ¥50,000 million share repurchase shapes...
TSE:2914
TSE:2914Tobacco

Japan Tobacco (TSE:2914) Earnings Growth And 15.5% Margin Test Bullish Narratives

Japan Tobacco (TSE:2914) has put up a solid set of FY 2025 numbers so far, with Q2 revenue at ¥907.6 billion and basic EPS of ¥91.49, following Q1 revenue of ¥827.0 billion and EPS of ¥88.69 as investors track how earnings and top line are shaping up through the year. Looking back over recent periods, revenue has moved from ¥740.3 billion in Q1 2024 to ¥829.6 billion in Q2 2024, then to ¥756.5 billion in Q4 2024 before reaching the current FY 2025 levels. EPS has ranged from a loss of ¥148.22...
TSE:4528
TSE:4528Pharmaceuticals

Assessing Ono Pharmaceutical (TSE:4528) Valuation After Improved Nine Month Earnings

Why Ono Pharmaceutical’s latest earnings matter for shareholders Ono Pharmaceutical (TSE:4528) has drawn fresh attention after reporting nine month results to December 31, 2025, with sales of ¥397,036 million and net income of ¥68,949 million, both above the prior year period. See our latest analysis for Ono Pharmaceutical. The latest nine month earnings update appears to have supported sentiment, with a 1 day share price return of 1.26% and a 30 day share price return of 11.03%. The 1 year...